A new microfluidic technology that leverages immune cell behavior is set to transform cancer monitoring, thanks to ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...

* Irregular sleep patterns nearly double the risk of depression relapse * Wearable devices can detect relapse risk weeks or months before symptoms //appear * Less difference between daytime activity ...

Fred D. Lublin, MD, discusses evolving concepts in MS, including earlier high-efficacy therapy, unrecognized progression, and ...

Adding belzutifan to pembrolizumab after kidney cancer surgery cuts recurrence risk by 28%, helping high-risk patients stay ...